This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of California. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations of Xiaohong Chen in Cancer Treatment
Introduction
Xiaohong Chen is a prominent inventor based in Santa Monica, CA (US). She has made significant contributions to the field of cancer research, particularly in the modulation of the WNT/beta-catenin pathway. Her work is crucial for developing new therapeutic strategies for colorectal cancer and other related conditions.
Latest Patents
Xiaohong Chen holds a patent for "Inhibitors of the WNT/beta-catenin pathway." This patent relates to compounds that can effectively modulate the WNT/Beta-Catenin pathway. The implications of her research are profound, as it provides methods for treating colorectal cancer and other cancers mediated by the WNT/Beta-Catenin pathway. She has 1 patent to her name.
Career Highlights
Xiaohong Chen is affiliated with the University of California, where she conducts her research. Her work has garnered attention for its potential impact on cancer therapies. She is recognized for her innovative approach to understanding and manipulating cellular pathways involved in cancer progression.
Collaborations
Xiaohong Chen has collaborated with notable researchers, including Michael E Jung and Cun-Yu Wang. These collaborations have further enhanced the depth and reach of her research efforts.
Conclusion
Xiaohong Chen's contributions to cancer research through her innovative patent work exemplify the importance of scientific inquiry in developing new treatment options. Her dedication to understanding complex biological pathways continues to pave the way for advancements in oncology.